- Comment in:
-
Gastroenterology. 1998 Jun;114(6):1351-2.
Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis.
Pensati L,
Costanzo A,
Ianni A,
Accapezzato D,
Iorio R,
Natoli G,
Nisini R,
Almerighi C,
Balsano C,
Vajro P,
Vegnente A,
Levrero M.
Dipartmento di Pediatria, Università degli Studi di Napoli Federico II, Naples, Italy.
Inherited mutations of the Fas/Apo1/CD95 gene, a cell-surface receptor involved in cell death signaling and in the control of self-reactivity, characterize the recently identified autoimmune lymphoproliferative syndromes. A patient with type 2 autoimmune hepatitis with the immunologic and genetic features of autoimmune lymphoproliferative syndrome is described. The clinical picture was dominated by liver disease with hepatosplenomegaly and positivity for anti-liver-kidney microsome 1 and anti-liver-cytosol 1 antibodies. A marked increase in CD3+CD4-CD8-T lymphocytes and inherited mutations in Fas alleles that led to the expression of a soluble form of the protein were also found. Fas-mediated apoptosis was deficient in the patient as it was in her mother and her sister, who carried the same allele 2 mutation. This observation links type 2 autoimmune hepatitis, an organ-specific disease, with a genetically determined defect in peripheral tolerance control.
PMID: 9322534 [PubMed - indexed for MEDLINE]